UA66783C2 - Antigestagenic steroids - Google Patents

Antigestagenic steroids

Info

Publication number
UA66783C2
UA66783C2 UA99094999A UA99094999A UA66783C2 UA 66783 C2 UA66783 C2 UA 66783C2 UA 99094999 A UA99094999 A UA 99094999A UA 99094999 A UA99094999 A UA 99094999A UA 66783 C2 UA66783 C2 UA 66783C2
Authority
UA
Ukraine
Prior art keywords
stands
group
hydrogen atom
steroids
hydrogen
Prior art date
Application number
UA99094999A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UA66783C2 publication Critical patent/UA66783C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA99094999A 1997-02-07 1998-02-09 Antigestagenic steroids UA66783C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19706061A DE19706061A1 (de) 1997-02-07 1997-02-07 Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
PCT/EP1998/000752 WO1998034947A1 (de) 1997-02-07 1998-02-09 ANTIGESTAGEN WIRKSAME STEROIDE MIT FLUORIERTER 17α-ALKYLKETTE

Publications (1)

Publication Number Publication Date
UA66783C2 true UA66783C2 (en) 2004-06-15

Family

ID=7820508

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99094999A UA66783C2 (en) 1997-02-07 1998-02-09 Antigestagenic steroids

Country Status (35)

Country Link
US (4) US6316432B1 (xx)
EP (1) EP0970103B1 (xx)
JP (1) JP4324249B2 (xx)
KR (1) KR100511815B1 (xx)
CN (2) CN1246865A (xx)
AR (1) AR010887A1 (xx)
AT (1) ATE216397T1 (xx)
AU (1) AU742834B2 (xx)
BG (1) BG63875B1 (xx)
BR (1) BR9807667A (xx)
CA (1) CA2280041C (xx)
CL (1) CL2004001191A1 (xx)
CZ (1) CZ296328B6 (xx)
DE (2) DE19706061A1 (xx)
DK (1) DK0970103T3 (xx)
EA (1) EA003092B1 (xx)
EE (1) EE03831B1 (xx)
ES (1) ES2175673T3 (xx)
HK (1) HK1040718B (xx)
HU (1) HUP0000968A3 (xx)
ID (1) ID22643A (xx)
IL (1) IL131226A (xx)
IS (1) IS2190B (xx)
MY (1) MY118508A (xx)
NO (1) NO313554B1 (xx)
NZ (1) NZ336989A (xx)
PL (1) PL191808B1 (xx)
PT (1) PT970103E (xx)
SI (1) SI0970103T1 (xx)
SK (1) SK283155B6 (xx)
TR (1) TR199901855T2 (xx)
TW (1) TW499434B (xx)
UA (1) UA66783C2 (xx)
WO (1) WO1998034947A1 (xx)
ZA (1) ZA98985B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE10049736A1 (de) * 2000-09-29 2002-04-18 Jenapharm Gmbh 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
UY26965A1 (es) * 2000-10-18 2002-06-20 Schering Ag Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
PT1326617E (pt) * 2000-10-18 2006-12-29 Schering Ag Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma
PL366415A1 (en) * 2000-10-18 2005-01-24 Schering Aktiengesellschaft Inhibition of the growth factor dependency of tumor cells
KR100632908B1 (ko) * 2000-10-18 2006-10-13 쉐링 악티엔게젤샤프트 호르몬-의존성 질병의 예방 및 치료를 위한항프로게스틴의 용도
DE10051609A1 (de) * 2000-10-18 2002-05-02 Schering Ag Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen
UY26966A1 (es) * 2000-10-18 2002-06-20 Schering Ag Uso de antiprogestinas para la inducción de apoptosis en una célula
US20020143000A1 (en) * 2001-01-09 2002-10-03 Christa Hegele-Hartung Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
ES2290284T3 (es) * 2001-01-09 2008-02-16 Bayer Schering Pharma Aktiengesellschaft El uso de antigestagenos para inhibir la maduracion endometrial acelerada durante el tratamiento de infertilidad.
US20030013694A1 (en) * 2001-05-25 2003-01-16 Jens Hoffmann Use and compositions of antiprogestins for treatment of prostate diseases
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
DE10221034A1 (de) 2002-05-03 2003-11-20 Schering Ag 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE50301507D1 (de) * 2002-05-03 2005-12-01 Schering Ag 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
SI1663978T1 (sl) 2003-07-23 2008-02-29 Bayer Pharmaceuticals Corp Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj
US7593347B2 (en) * 2003-12-29 2009-09-22 Intel Corporation Method and apparatus to exchange channel information
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
EA017227B1 (ru) 2006-10-24 2012-10-30 Репрос Терапьютикс Инк. Способ лечения эстрогензависимого состояния
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
WO2008128791A2 (en) * 2007-04-23 2008-10-30 Bayer Schering Pharma Aktiengesellschaft Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
EP2123279A1 (de) * 2008-05-14 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Sequentielle Verabreichung von 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on und einem oder mehreren Gestagenen zur Behandlung gynäkologischer Erkrankungen
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
UA110030C2 (uk) 2010-03-22 2015-11-10 Спосіб лікування ендометріозу або міоми матки і лікарська форма для щоденного введення на слизову піхви жінки
DE102010030538A1 (de) 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011004899A1 (de) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
DE102011087987A1 (de) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
WO2014166971A1 (en) 2013-04-11 2014-10-16 Bayer Pharma Aktiengesellschaft Progesterone receptor antagonist dosage form
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
EP2868321A1 (en) * 2013-11-03 2015-05-06 Flamina Holding AG A composition or group of compositions for inhibiting autocrine HCG production in adult human cells
US9603856B2 (en) 2013-11-03 2017-03-28 Flamina Holding Ag Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
SG10201910441PA (en) 2015-05-18 2020-01-30 Bayer Pharma AG Selective progesterone receptor modulator (sprm) regimen
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE310541C (xx) * 1915-12-19 1919-01-30
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2639045B2 (fr) 1982-03-01 1994-07-29 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
US5064821A (en) * 1982-11-18 1991-11-12 Trustees Of Tufts College Method and compositions for overcoming tetracycline resistance within living cells
FR2598421B1 (fr) * 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US5272140A (en) * 1987-01-23 1993-12-21 Akzo N.V. 11-aryl steroid derivatives
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3733478A1 (de) 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
JP2785023B2 (ja) * 1987-12-30 1998-08-13 ルセル―ユクラフ １７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
EP0369881A1 (fr) * 1988-11-16 1990-05-23 Roussel-Uclaf Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
CN1055929C (zh) * 1993-09-20 2000-08-30 中国科学院上海有机化学研究所 三氟甲基甾体化合物及其制备方法
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
CN1324802A (zh) 2001-12-05
CA2280041C (en) 2007-10-23
NO313554B1 (no) 2002-10-21
CZ296328B6 (cs) 2006-02-15
EA003092B1 (ru) 2002-12-26
HUP0000968A3 (en) 2001-03-28
IL131226A (en) 2004-12-15
ID22643A (id) 1999-12-02
EP0970103B1 (de) 2002-04-17
DE59803856D1 (de) 2002-05-23
AR010887A1 (es) 2000-07-12
SK283155B6 (sk) 2003-03-04
CZ280599A3 (cs) 2000-01-12
US20030134834A1 (en) 2003-07-17
WO1998034947A1 (de) 1998-08-13
JP2001510479A (ja) 2001-07-31
IL131226A0 (en) 2001-01-28
SK103899A3 (en) 2000-05-16
TR199901855T2 (xx) 2000-04-21
EE9900339A (et) 2000-02-15
JP4324249B2 (ja) 2009-09-02
ZA98985B (en) 1999-08-03
AU742834B2 (en) 2002-01-10
HK1040718B (zh) 2005-12-09
ATE216397T1 (de) 2002-05-15
US20050080060A1 (en) 2005-04-14
ES2175673T3 (es) 2002-11-16
SI0970103T1 (en) 2002-10-31
NO993811L (no) 1999-10-04
CN1246865A (zh) 2000-03-08
NZ336989A (en) 2001-04-27
HK1040718A1 (en) 2002-06-21
IS5147A (is) 1999-08-04
US20020045774A1 (en) 2002-04-18
CL2004001191A1 (es) 2005-03-28
BR9807667A (pt) 2000-02-15
PL191808B1 (pl) 2006-07-31
KR100511815B1 (ko) 2005-09-05
BG63875B1 (bg) 2003-04-30
AU6100598A (en) 1998-08-26
NO993811D0 (no) 1999-08-06
PL334878A1 (en) 2000-03-27
IS2190B (is) 2007-01-15
US7148213B2 (en) 2006-12-12
EE03831B1 (et) 2002-08-15
US6806263B2 (en) 2004-10-19
TW499434B (en) 2002-08-21
HUP0000968A2 (hu) 2000-10-28
KR20000070835A (ko) 2000-11-25
PT970103E (pt) 2002-09-30
BG103603A (en) 2000-06-30
MY118508A (en) 2004-11-30
US6503895B2 (en) 2003-01-07
EP0970103A1 (de) 2000-01-12
CA2280041A1 (en) 1998-08-13
US6316432B1 (en) 2001-11-13
EA199900644A1 (ru) 2000-04-24
DK0970103T3 (da) 2002-07-22
CN1202120C (zh) 2005-05-18
DE19706061A1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
UA66783C2 (en) Antigestagenic steroids
HUT77088A (hu) Hipokoleszterinémiás szerekként használható kénszubsztituált azetidinon-vegyületek és ezeket tartalmazó gyógyszerkészítmények
TW427974B (en) Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
PL343360A1 (en) Fatty acid derivatives of bile acids and bile acid derivatives
IL105078A (en) Pharmaceutical compositions containing 17-(3-pyridyl)- substituted steroids and some new compounds of this type
TR199900293T2 (xx) Alzheimer hastal��� tedavisi i�in bir farmas�tik bile�im �retmek �zere �elat maddesi clioquil'un kullan�m�.
HK1052684A1 (en) Inhibitors of alpha 4 mediated cell adhesion.
NZ312303A (en) Novel nor-pregnanes for inducing hypothalamic effects
RU97104003A (ru) Производные эстра-1,3,5(10)-триена, способ их получения и содержащие их фармацевтические композиции
HK1018590A1 (en) Administration regimen of h+, k+-atpase inhibitors
HUP0104841A2 (hu) Hatóanyagként NF-kB gátló hatású benzokinonszármazékot vagy kondenzált pirimidinszármazékot tartalmazó gyógyszerkészítmények szívizomgyulladás, dilatatív kardiomiopátia vagy szívelégtelenség kezelésére
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
BG102661A (en) Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors
EP0972766A4 (en) HYDROQUINONE DERIVATIVES
HUP0003693A2 (hu) Oxidációs bázisként pirazolo[1,5-a]pirimidint és kapcsolóként naftalint tartalmazó festékkészítmény és festési eljárás ennek alkalmazásával
TW333536B (en) 14-17-C2-bridged steroids
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
HUP0200913A2 (hu) Izoindoloindolonszármazékok eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
WO2003013420A3 (en) Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification
AU3266089A (en) New triene derivatives having a chromene structure, processes for preparing them and pharmaceutical compositions containing them
TH35006A (th) สเทอรอยด์ที่ว่องไวในการต่อต้านเจสทาเจนที่มีโซ่ฟลูออริเนเทค 17 อัลฟา-แอลคิล
HUP0402139A2 (hu) Hormon hatású 17 alfa-hidroxi-14 béta-szteroidok és alkalmazásuk gyógyszerkészítmények előállítására
AU2507501A (en) 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
MY113797A (en) 14alpha, alpha 17 -c2-bridged norprogesterone derivatives
ES342459A1 (es) Procedimiento para la obtencion de derivados de la teofili-na.